The paper details a comprehensive study of nuclear-embedded mitochondrial DNA (NUMT), which are segments of mitochondrial genetic material that have transitioned into the human and primate nuclear genomes over evolutionary history. Utilizing advanced long-read sequencing and pangenome graph-based detection, researchers identified over 1,100 human NUMTs, distinguishing between fixed events present in all individuals and polymorphic variants that vary across populations. The study reveals that these insertions are not merely "genomic fossils" but dynamic components that can influence gene expression, splicing, and structural variation. Comparative analysis across primate lineages shows that lineage-specific insertion rates and genomic duplications drive NUMT expansion, particularly within the Pan lineage. Furthermore, the findings highlight a selective pressure against certain mitochondrial sequences in the nuclear environment and identify NUMTs as a novel source for variable number tandem repeats (VNTRs). This research ultimately establishes a high-resolution map that enhances our understanding of genomic architecture and its biomedical relevance. References: * Fu L, Chen J, Lian D, et al. A long-read human pangenome initiative for comprehensive interpretation of nuclear-embedded mitochondrial DNA[J]. Nature Communications, 2026, 17(1): 4371.

This study presents a comparative transcriptomic atlas that evaluates how well mouse models of demyelination mimic the cellular landscape of human multiple sclerosis (MS). By integrating single-cell and single-nucleus RNA sequencing datasets, researchers discovered that the cuprizone (CPZ) model uniquely produces a stressed oligodendrocyte state While both the CPZ and lysophosphatidylcholine (LPC) models converge on a shared immune-responsive state that closely mirrors the transcriptional dysfunction found in human Multiple Sclerosis lesions. during the repair phase, they only partially capture the diversity of progenitor and microglial cells seen in patients. The findings reveal that while mouse models exhibit a conserved core of microglial activation, they lack the full range of cellular heterogeneity present in the chronic stages of human disease. Ultimately, this research provides a harmonized framework to help scientists strategically select the most appropriate animal models for studying myelin injury and testing new neuroregenerative therapies. References: * Aboelnour E L, Vanoverbeke V R, Maupin E A, et al. A comparative transcriptomic analysis of mouse demyelination models and Multiple Sclerosis lesions[J]. Nature Communications, 2026, 17(1): 3858.

This study presents an exome-wide association study involving over 1.1 million individuals from diverse global populations to investigate the genetic basis of blood lipid levels. By analyzing nearly 3 million rare coding variants, researchers identified 800 significant associations linked to conditions like dyslipidemia and coronary artery disease. The findings reveal that rare variants significantly influence lipid traits across different ancestries, offering new insights into the pathogenicity of previously misunderstood genetic markers. Notably, the research highlights RORC as a potential drug target for lowering cholesterol levels. Ultimately, this large-scale analysis provides a robust framework for improving clinical diagnoses and developing precision therapies for cardiovascular health. References: * Koyama, S., Yu, Z., Choi, S.H. et al. Exome-wide association study of blood lipids in 1,158,017 individuals from diverse populations. Nat Genet (2026). https://doi.org/10.1038/s41588-026-02613-y

Researchers utilized whole-genome sequencing to investigate mosaic chromosomal alterations (mCAs) within the blood of nearly half a million participants from the UK Biobank. By developing a high-resolution computational method, the study identified over 43,000 alterations, revealing a significant increase in detection sensitivity compared to traditional techniques. This approach uncovered numerous genomic hotspots for short mutations and provided insights into the DNA-repair mechanisms that drive these changes as people age. The findings highlight how specific chromosomal deletions are linked to chronic lymphocytic leukemia, offering new potential for clinical screening. Additionally, the research identifies inherited genetic variants that influence the expansion of these mutations, illustrating the predictable ways in which the blood genome evolves over a lifetime. References: * Tang D, Kamitaki N, Mukamel R E, et al. Patterns and drivers of 43,617 mosaic chromosomal alterations in blood[J]. Nature Genetics, 2026: 1-12.

This research identifies a self-contained ketogenic pathway that is essential for the survival of leukemic stem cells (LSCs) in acute myeloid leukemia. While ketone production is typically associated with the liver, these malignant cells utilize fatty acid oxidation to generate the ketone body BHB, which acts as a protective shield against cell death. This metabolic process works by epigenetically suppressing the enzyme FADS2, thereby preventing the remodeling of lipids into forms that are susceptible to ferroptosis, a type of iron-dependent oxidative rupture. Crucially, experimental deletion of the rate-limiting enzyme HMGCS2 successfully eliminated these cancer-initiating cells and halted disease progression in both mouse models and human samples. Because this pathway is specifically active in malignant cells, targeting it offers a promising therapeutic strategy to selectively destroy leukemia while leaving healthy blood-forming cells unharmed. Overall, the study reveals that autonomous ketogenesis is a hallmark of cancer stemness that maintains the structural integrity of the cell membrane under metabolic stress. References: * Han X, Wang K, Ma W, et al. A ketogenesis-ferroptosis axis maintains leukemic stem cell survival and leukemia progression[J]. Cell Stem Cell, 2026.

This research identifies four unique leukemic stem cell (LSC) subtypes in acute myeloid leukemia that dictate how patients respond to the drug venetoclax. By profiling over 150 patients, the study reveals that therapy resistance is driven by the specific differentiation state and plasticity of these stem cells. A major finding is the discovery of MoDe-LSCs, a mature monocytic subtype identified by the marker LAMP5 that consistently resists standard treatments. The authors demonstrate that these resistant cells can be neutralized by targeting specific survival proteins, such as using MEK1/2 inhibitors for LAMP5+ cells. Ultimately, this framework provides a biomarker-guided strategy to overcome drug resistance through personalized clinical approaches. These findings suggest that subtyping LSCs can significantly improve genetic risk stratification and treatment outcomes for high-risk leukemia. References: * Waclawiczek A, Leppä A M, Renders S, et al. Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML[J]. Cell stem cell, 2026.

This research introduces pleiotropic chimeric antigen receptor-monocytes (pCAR-Mos) as a dual-action cell therapy designed to treat heart failure following a myocardial infarction. By engineering monocytes to target fibroblast activation protein (FAP) and secrete the regenerative protein Agrin, the study demonstrates a synergistic approach that clears pathogenic fibrosis while simultaneously promoting cardiomyocyte proliferation and angiogenesis. Unlike traditional CAR-T or CAR-macrophage treatments, these engineered monocytes show superior cardiac homing capabilities and a more favorable distribution within injured tissues. Experimental results in mice reveal that this treatment significantly reduces infarct size, restores cardiac function, and reshapes the fibrotic microenvironment without systemic toxicity. Single-nuclear RNA sequencing further confirms that pCAR-Mos effectively eliminate pathological fibroblast subsets and foster a pro-regenerative environment for heart repair. In summary, the study presents a reversible and highly efficient adoptive cell therapy that addresses the critical medical need for both scar reduction and muscle regrowth in ischemic heart disease. References: * Wu Z, Zou X, Chen C, et al. Engineered CAR-monocytes coordinate fibrosis clearance and cardiac regeneration following myocardial infarction[J]. Cell Stem Cell, 2026.

This research explores how hyocholic acids (HCAs), a primary bile acid produced by the fetal liver, act as a vital immunological buffer during early development. While HCAs are scarce in adults, they dominate neonatal meconium and serum, playing a central role in establishing immune tolerance by promoting anti-inflammatory Treg cells while suppressing pro-inflammatory Th17 cells. This metabolic window facilitates the healthy colonization of beneficial gut microbiota, such as Bifidobacterium, while protecting infants from pathogens and gastrointestinal disorders like necrotizing enterocolitis. Clinical data further demonstrates that high neonatal HCA levels correlate with a significantly lower risk of infections and inflammatory conditions during the first year of life. Ultimately, the study identifies HCAs as a unique class of primary bile acids essential for orchestrating the early-life immune-microbiome axis. References: * Zheng X, Wang J, Sun Y, et al. Hyocholic acids shape neonatal immune tolerance and microbiota assembly[J]. Cell Metabolism, 2026.

This article from Cancer Cell investigates why some urothelial cancers develop resistance to the antibody-drug conjugate (ADC) Enfortumab vedotin (NECTIN4-ADC). Using single-cell RNA sequencing and spatial transcriptomics, researchers identified a specific tumor cell subpopulation that remains high in NECTIN4 expression but evades treatment through endocytic trafficking defects. The study reveals that the protein AKR1C1 blocks the internalization of the drug and works with WWP2 to export the ADC out of the cell via extracellular vesicles. This resistance state is driven by the transcription factor ELF3, which regulates both the drug target and the resistance-associated proteins. Crucially, the authors demonstrate that pharmacological inhibition of AKR1C1 restores drug uptake and significantly improves the effectiveness of ADC therapy in preclinical models. This discovery offers a promising strategy to overcome clinical resistance by targeting the mechanisms that control membrane trafficking and drug delivery. References: * Wang Y, Chen Z, Wang W, et al. Endocytic evasion confers resistance to antibody-drug conjugates therapy in cancer[J]. Cancer Cell, 2026.

Researchers have developed a sophisticated tri-assembloid model that mimics the human sinoatrial node (SAN) and its complex interaction with the autonomic nervous system. By integrating human pluripotent stem cell-derived pacemaker organoids with cardiac plexus and atrial organoids, the study successfully recreates the electrical conduction axis and neural regulation of heart rate. This platform allowed for the discovery of a specific PSAP-GPR37 signaling pathway that is essential for the functional maturation of pacemaker cells. Furthermore, the model serves as a powerful tool for disease modeling, demonstrating how genetic mutations like KCNJ3 contribute to heart rhythm disorders such as bradycardia. Through the use of spatial transcriptomics, the study provides a high-resolution map of the human embryonic heart, bridging the gap between anatomical structure and physiological function. Ultimately, these neuro-cardiac assembloids offer a novel human-specific system for testing pharmacological treatments and understanding the fundamental biology of the heart's natural pacemaker. References: * Zhang T, Fan L, Yao F, et al. Human PSC-derived sinoatrial node-cardiac plexus assembloids model innervation-associated maturation of pacemaker systems[J]. Cell Stem Cell, 2026.

This research utilized spatial transcriptomics to map the complex temporal and physical organization of spermatogenesis in mouse testes. By analyzing nearly 900,000 cells at single-molecule resolution, the authors reconstructed the seminiferous epithelial cycle, identifying a circular transcriptional topology that governs tissue timing. A major discovery is that Sertoli cells possess an intrinsic oscillatory program that persists even when germ cells are absent. The study identifies retinoic acid as a vital permissive signal for this cycle, while paracrine cues like Wnt signaling help refine and synchronize the process. Ultimately, the findings provide an integrative model of how intrinsic cellular rhythms and intercellular communication coordinate continuous sperm production. References: * Chakravorty A, Yun J, Amrhein H, et al. The temporal architecture of the seminiferous epithelial cycle revealed by spatial transcriptomics[J]. Cell, 2026.

Using transcriptome-wide CRISPR-Cas13 screens, researchers identified nearly 800 essential long noncoding RNAs (lncRNAs) that are critical for human cell survival and proliferation across various cell lines. While most of these molecules function in a cell-type-specific manner, a core group of 15 lncRNAs was found to be essential across multiple contexts. Significantly, the study demonstrates that these lncRNAs typically operate independently of neighboring protein-coding genes, challenging the idea that they only regulate nearby genomic elements. By integrating single-cell sequencing and developmental atlases, the authors discovered that these essential transcripts are dynamically expressed during human embryonic development and often correlate with tumor progression. Ultimately, this research provides a functional map of the noncoding genome, highlighting these lncRNAs as potential biomarkers and therapeutic targets for cancer. References: * Liang W W, Mueller S J, Hart S K, et al. Essential lncRNAs in the human transcriptome[J]. Cell Genomics, 2026.

This research examines the critical link between chronic inflammation and accelerated biological aging. By analyzing four diverse groups of people, scientists discovered that inflammatory proteins related to the interferon pathway do not just correlate with aging but actually serve as causal drivers of epigenetic age acceleration. The findings highlight that epigenetic clocks focused on health span, such as GrimAge and PhenoAge, are superior at predicting multimorbidity and frailty compared to traditional lifespan-based measures. Ultimately, the authors propose that targeting these specific immune signals could provide a viable pathway for developing new anti-aging therapies to improve long-term health. References: * Liu Z, Ziogas A, Zhang Y, et al. Interferon-related inflammaging links epigenetic age acceleration to multimorbidity[J]. Cell Genomics, 2026.

ProtoCloud is a sophisticated deep learning model designed to enhance the accuracy and transparency of single-cell genomic analysis. By organizing data around cell-type-specific prototypes, the system provides dual-level interpretability that explains both individual cell classifications and the specific genes driving those decisions. A unique disentangled latent space allows the model to separate essential biological identities from technical noise, such as batch effects, without requiring external metadata. Beyond standard annotation, the model features an uncertainty estimation mechanism that identifies and corrects mislabeled cells while discovering rare populations. Evidence from diverse experiments confirms that ProtoCloud outperforms existing methods, offering a robust framework for building reliable cellular atlases and tracking temporal biological changes. References: * Guo K, Ding J. ProtoCloud: a Prototypical Self-explaining Model for Single-cell Analysis[J]. bioRxiv, 2026: 2026.02. 06.704364.

Researchers have developed ChromBERT, a genomic foundation model designed to decode the complex "syntax" of interactions among over 1,000 transcription regulators. By pre-training on a massive dataset of human ChIP-seq profiles, the model creates interpretable representations of regulatory networks that function across diverse cell types. ChromBERT excels at cistrome imputation, accurately predicting binding events in unseen cells by using fine-tuning prompts from chromatin accessibility or transcriptomes. Beyond simple prediction, the model identifies key regulatory drivers behind cell state transitions and enhancer activity without requiring new, expensive experiments. Ultimately, this technology overcomes the challenge of sparse data to reveal the hierarchical mechanisms governing gene expression in both healthy and diseased tissues. References: * Yu Z, Yang D, Chen Q, et al. ChromBERT: A foundation model for learning interpretable representations for context-specific transcriptional regulatory networks[J]. Cell Genomics, 2026.